about
Functional connectivity in the basal ganglia network differentiates PD patients from controlsPredictors of cognitive impairment in an early stage Parkinson's disease cohortAberrant functional connectivity within the basal ganglia of patients with Parkinson's diseaseChallenges in the reproducibility of clinical studies with resting state fMRI: An example in early Parkinson's disease.Modulation of hippocampal theta and hippocampal-prefrontal cortex function by a schizophrenia risk geneParkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery CohortVisual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson's disease.Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's diseaseDelineating nonmotor symptoms in early Parkinson's disease and first-degree relativesAlpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease.Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorder.Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.Apathy in rapid eye movement sleep behaviour disorder is common and under-recognized.The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder.Exploring variability in basal ganglia connectivity with functional MRI in healthy aging.Cortical structural involvement and cognitive dysfunction in early Parkinson's disease.Tackling dementia in patients with Parkinson's disease.Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cellsSmartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PDRisk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre studySubcutaneous panniculitis-like T-cell lymphomaMortality from Listeria monocytogenes meningoencephalitis following escalation to alemtuzumab therapy for relapsing-remitting Multiple SclerosisContinuous Real-World Gait Monitoring in Idiopathic REM Sleep Behavior DisorderImpulse control disorders in Parkinson disease and RBD: A longitudinal study of severity
P50
Q33981257-BE85324D-F304-4E35-9BEA-54C6F1E95250Q34531319-4797714D-6369-414E-B357-33807BF93AA3Q35759065-21430590-1310-44AF-8C0C-A83DC6E697F9Q36307159-54086089-4DC1-460F-A58F-92EB5033E6B2Q36354639-FC5EC09E-6D11-4FA7-9DC8-C59BCA04E552Q37044196-743AF529-4CEA-4D38-BD49-00E06EEF983AQ37104904-7BB2EDCA-19F8-419B-9AD9-085957D6EC83Q37121555-C546FBA7-F35C-4A1B-80A8-D695BFC78403Q37279420-041E00B8-2B72-45F1-8E25-1CD7BD87F270Q37307515-C5F45B5A-D24D-4F12-A899-0755C193359AQ37716114-3212BF3A-534F-4FDF-A352-0CFDD7332A7BQ37737516-D1874BE9-C196-4AC4-8D26-F79AEA6FA22EQ47323174-8F4AE403-0742-4F1A-B61F-C8E0310D05ABQ47664948-D68F9EAC-9693-4929-AD31-5CA50211D1A2Q47796869-0B05B688-FC47-4609-9806-57DD45A76291Q50016463-7902FF90-654E-426D-A0B1-B232A7798B8EQ50050021-C8F788B5-4779-4119-B25D-307B9F535868Q50434704-F43F425E-B7F1-4070-A541-8DC28307BD03Q57183034-F9F29674-9912-47EF-9E2A-E6DE87155913Q57459510-7DE50BCA-B1F7-4808-B954-8DBEE8BD7138Q64230190-350AE57D-E64F-4D10-B425-EFE1FF19F2ADQ84424711-9C061FDE-02D4-4C98-9EC9-A46F67FD3F2DQ89050024-08B4623D-345F-4469-BF56-D62134E6712CQ91467900-B4E940B4-582F-440A-A237-E52C77303003Q91935757-651B8EC9-F5E6-42AE-A815-0BCAE52EF570
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michal Rolinski
@ast
Michal Rolinski
@en
Michal Rolinski
@es
Michal Rolinski
@nl
Michal Rolinski
@sl
type
label
Michal Rolinski
@ast
Michal Rolinski
@en
Michal Rolinski
@es
Michal Rolinski
@nl
Michal Rolinski
@sl
altLabel
Harry Rolinski
@en
prefLabel
Michal Rolinski
@ast
Michal Rolinski
@en
Michal Rolinski
@es
Michal Rolinski
@nl
Michal Rolinski
@sl
P106
P1153
37028938400
P21
P31
P4012
P496
0000-0003-1191-7060